Adalimumab, sold under the brand name?Humira, among others, is a?monoclonal antibody?used to treat?rheumatoid arthritis,?psoriatic arthritis,?ankylosing spondylitis,?Crohn's disease,?ulcerative colitis,?plaque psoriasis,?hidradenitis suppurativa,?uveitis, and?juvenile idiopathic arthritis.[23][24][25]?It is administered by?injection under the skin.
The global market for Adalimumab Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Adalimumab Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Adalimumab Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Adalimumab Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Adalimumab Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Adalimumab Drug players cover Cambridge Antibody Technology, BASF, AbbVie, MABURA and Exemptia, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Adalimumab Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Adalimumab Drug market, with both quantitative and qualitative data, to help readers understand how the Adalimumab Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Adalimumab Drug market and forecasts the market size by Type (Adalimumab and Adalimumab Biosimilar,), by Application (Adult and Children.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Adalimumab
Adalimumab Biosimilar
Segmentation by application
Adult
Children
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Cambridge Antibody Technology
BASF
AbbVie
MABURA
Exemptia
Amgen
Sandoz
Boehringer Ingelheim
Mylan
Biogen
Chapter Introduction
Chapter 1: Scope of Adalimumab Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Adalimumab Drug market size and CAGR, Adalimumab Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Adalimumab Drug revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Adalimumab Drug revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Adalimumab Drug market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Cambridge Antibody Technology, BASF, AbbVie, MABURA, Exemptia, Amgen, Sandoz, Boehringer Ingelheim and Mylan, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Adalimumab Drug Market Size 2017-2028
2.1.2 Adalimumab Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Adalimumab Drug Segment by Type
2.2.1 Adalimumab
2.2.2 Adalimumab Biosimilar
2.3 Adalimumab Drug Market Size by Type
2.3.1 Adalimumab Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Adalimumab Drug Market Size Market Share by Type (2017-2022)
2.4 Adalimumab Drug Segment by Application
2.4.1 Adult
2.4.2 Children
2.5 Adalimumab Drug Market Size by Application
2.5.1 Adalimumab Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Adalimumab Drug Market Size Market Share by Application (2017-2022)
3 Adalimumab Drug Market Size by Player
3.1 Adalimumab Drug Market Size Market Share by Players
3.1.1 Global Adalimumab Drug Revenue by Players (2020-2022)
3.1.2 Global Adalimumab Drug Revenue Market Share by Players (2020-2022)
3.2 Global Adalimumab Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Adalimumab Drug by Regions
4.1 Adalimumab Drug Market Size by Regions (2017-2022)
4.2 Americas Adalimumab Drug Market Size Growth (2017-2022)
4.3 APAC Adalimumab Drug Market Size Growth (2017-2022)
4.4 Europe Adalimumab Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Adalimumab Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Adalimumab Drug Market Size by Country (2017-2022)
5.2 Americas Adalimumab Drug Market Size by Type (2017-2022)
5.3 Americas Adalimumab Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adalimumab Drug Market Size by Region (2017-2022)
6.2 APAC Adalimumab Drug Market Size by Type (2017-2022)
6.3 APAC Adalimumab Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Adalimumab Drug by Country (2017-2022)
7.2 Europe Adalimumab Drug Market Size by Type (2017-2022)
7.3 Europe Adalimumab Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Adalimumab Drug by Region (2017-2022)
8.2 Middle East & Africa Adalimumab Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Adalimumab Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Adalimumab Drug Market Forecast
10.1 Global Adalimumab Drug Forecast by Regions (2023-2028)
10.1.1 Global Adalimumab Drug Forecast by Regions (2023-2028)
10.1.2 Americas Adalimumab Drug Forecast
10.1.3 APAC Adalimumab Drug Forecast
10.1.4 Europe Adalimumab Drug Forecast
10.1.5 Middle East & Africa Adalimumab Drug Forecast
10.2 Americas Adalimumab Drug Forecast by Country (2023-2028)
10.2.1 United States Adalimumab Drug Market Forecast
10.2.2 Canada Adalimumab Drug Market Forecast
10.2.3 Mexico Adalimumab Drug Market Forecast
10.2.4 Brazil Adalimumab Drug Market Forecast
10.3 APAC Adalimumab Drug Forecast by Region (2023-2028)
10.3.1 China Adalimumab Drug Market Forecast
10.3.2 Japan Adalimumab Drug Market Forecast
10.3.3 Korea Adalimumab Drug Market Forecast
10.3.4 Southeast Asia Adalimumab Drug Market Forecast
10.3.5 India Adalimumab Drug Market Forecast
10.3.6 Australia Adalimumab Drug Market Forecast
10.4 Europe Adalimumab Drug Forecast by Country (2023-2028)
10.4.1 Germany Adalimumab Drug Market Forecast
10.4.2 France Adalimumab Drug Market Forecast
10.4.3 UK Adalimumab Drug Market Forecast
10.4.4 Italy Adalimumab Drug Market Forecast
10.4.5 Russia Adalimumab Drug Market Forecast
10.5 Middle East & Africa Adalimumab Drug Forecast by Region (2023-2028)
10.5.1 Egypt Adalimumab Drug Market Forecast
10.5.2 South Africa Adalimumab Drug Market Forecast
10.5.3 Israel Adalimumab Drug Market Forecast
10.5.4 Turkey Adalimumab Drug Market Forecast
10.5.5 GCC Countries Adalimumab Drug Market Forecast
10.6 Global Adalimumab Drug Forecast by Type (2023-2028)
10.7 Global Adalimumab Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Cambridge Antibody Technology
11.1.1 Cambridge Antibody Technology Company Information
11.1.2 Cambridge Antibody Technology Adalimumab Drug Product Offered
11.1.3 Cambridge Antibody Technology Adalimumab Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Cambridge Antibody Technology Main Business Overview
11.1.5 Cambridge Antibody Technology Latest Developments
11.2 BASF
11.2.1 BASF Company Information
11.2.2 BASF Adalimumab Drug Product Offered
11.2.3 BASF Adalimumab Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 BASF Main Business Overview
11.2.5 BASF Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Adalimumab Drug Product Offered
11.3.3 AbbVie Adalimumab Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 MABURA
11.4.1 MABURA Company Information
11.4.2 MABURA Adalimumab Drug Product Offered
11.4.3 MABURA Adalimumab Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 MABURA Main Business Overview
11.4.5 MABURA Latest Developments
11.5 Exemptia
11.5.1 Exemptia Company Information
11.5.2 Exemptia Adalimumab Drug Product Offered
11.5.3 Exemptia Adalimumab Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Exemptia Main Business Overview
11.5.5 Exemptia Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Adalimumab Drug Product Offered
11.6.3 Amgen Adalimumab Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Sandoz
11.7.1 Sandoz Company Information
11.7.2 Sandoz Adalimumab Drug Product Offered
11.7.3 Sandoz Adalimumab Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sandoz Main Business Overview
11.7.5 Sandoz Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Adalimumab Drug Product Offered
11.8.3 Boehringer Ingelheim Adalimumab Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Mylan
11.9.1 Mylan Company Information
11.9.2 Mylan Adalimumab Drug Product Offered
11.9.3 Mylan Adalimumab Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Mylan Main Business Overview
11.9.5 Mylan Latest Developments
11.10 Biogen
11.10.1 Biogen Company Information
11.10.2 Biogen Adalimumab Drug Product Offered
11.10.3 Biogen Adalimumab Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Biogen Main Business Overview
11.10.5 Biogen Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Adalimumab Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Adalimumab
Table 3. Major Players of Adalimumab Biosimilar
Table 4. Adalimumab Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Adalimumab Drug Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Adalimumab Drug Market Size Market Share by Type (2017-2022)
Table 7. Adalimumab Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Adalimumab Drug Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Adalimumab Drug Market Size Market Share by Application (2017-2022)
Table 10. Global Adalimumab Drug Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Adalimumab Drug Revenue Market Share by Player (2020-2022)
Table 12. Adalimumab Drug Key Players Head office and Products Offered
Table 13. Adalimumab Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Adalimumab Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Adalimumab Drug Market Size Market Share by Regions (2017-2022)
Table 18. Americas Adalimumab Drug Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Adalimumab Drug Market Size Market Share by Country (2017-2022)
Table 20. Americas Adalimumab Drug Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Adalimumab Drug Market Size Market Share by Type (2017-2022)
Table 22. Americas Adalimumab Drug Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Adalimumab Drug Market Size Market Share by Application (2017-2022)
Table 24. APAC Adalimumab Drug Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Adalimumab Drug Market Size Market Share by Region (2017-2022)
Table 26. APAC Adalimumab Drug Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Adalimumab Drug Market Size Market Share by Type (2017-2022)
Table 28. APAC Adalimumab Drug Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Adalimumab Drug Market Size Market Share by Application (2017-2022)
Table 30. Europe Adalimumab Drug Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Adalimumab Drug Market Size Market Share by Country (2017-2022)
Table 32. Europe Adalimumab Drug Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Adalimumab Drug Market Size Market Share by Type (2017-2022)
Table 34. Europe Adalimumab Drug Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Adalimumab Drug Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Adalimumab Drug Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Adalimumab Drug Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Adalimumab Drug Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Adalimumab Drug Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Adalimumab Drug Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Adalimumab Drug Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Adalimumab Drug
Table 43. Key Market Challenges & Risks of Adalimumab Drug
Table 44. Key Industry Trends of Adalimumab Drug
Table 45. Global Adalimumab Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Adalimumab Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Adalimumab Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Adalimumab Drug Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Adalimumab Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Adalimumab Drug Market Size Market Share Forecast by Application (2023-2028)
Table 51. Cambridge Antibody Technology Details, Company Type, Adalimumab Drug Area Served and Its Competitors
Table 52. Cambridge Antibody Technology Adalimumab Drug Product Offered
Table 53. Cambridge Antibody Technology Adalimumab Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Cambridge Antibody Technology Main Business
Table 55. Cambridge Antibody Technology Latest Developments
Table 56. BASF Details, Company Type, Adalimumab Drug Area Served and Its Competitors
Table 57. BASF Adalimumab Drug Product Offered
Table 58. BASF Main Business
Table 59. BASF Adalimumab Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. BASF Latest Developments
Table 61. AbbVie Details, Company Type, Adalimumab Drug Area Served and Its Competitors
Table 62. AbbVie Adalimumab Drug Product Offered
Table 63. AbbVie Main Business
Table 64. AbbVie Adalimumab Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. AbbVie Latest Developments
Table 66. MABURA Details, Company Type, Adalimumab Drug Area Served and Its Competitors
Table 67. MABURA Adalimumab Drug Product Offered
Table 68. MABURA Main Business
Table 69. MABURA Adalimumab Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. MABURA Latest Developments
Table 71. Exemptia Details, Company Type, Adalimumab Drug Area Served and Its Competitors
Table 72. Exemptia Adalimumab Drug Product Offered
Table 73. Exemptia Main Business
Table 74. Exemptia Adalimumab Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Exemptia Latest Developments
Table 76. Amgen Details, Company Type, Adalimumab Drug Area Served and Its Competitors
Table 77. Amgen Adalimumab Drug Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Adalimumab Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Amgen Latest Developments
Table 81. Sandoz Details, Company Type, Adalimumab Drug Area Served and Its Competitors
Table 82. Sandoz Adalimumab Drug Product Offered
Table 83. Sandoz Main Business
Table 84. Sandoz Adalimumab Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Sandoz Latest Developments
Table 86. Boehringer Ingelheim Details, Company Type, Adalimumab Drug Area Served and Its Competitors
Table 87. Boehringer Ingelheim Adalimumab Drug Product Offered
Table 88. Boehringer Ingelheim Main Business
Table 89. Boehringer Ingelheim Adalimumab Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Boehringer Ingelheim Latest Developments
Table 91. Mylan Details, Company Type, Adalimumab Drug Area Served and Its Competitors
Table 92. Mylan Adalimumab Drug Product Offered
Table 93. Mylan Main Business
Table 94. Mylan Adalimumab Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Mylan Latest Developments
Table 96. Biogen Details, Company Type, Adalimumab Drug Area Served and Its Competitors
Table 97. Biogen Adalimumab Drug Product Offered
Table 98. Biogen Main Business
Table 99. Biogen Adalimumab Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Biogen Latest Developments
List of Figures
List of Figures
Figure 1. Adalimumab Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Adalimumab Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Adalimumab Drug Market Size Market Share by Type in 2021
Figure 7. Adalimumab Drug in Adult
Figure 8. Global Adalimumab Drug Market: Adult (2017-2022) & ($ Millions)
Figure 9. Adalimumab Drug in Children
Figure 10. Global Adalimumab Drug Market: Children (2017-2022) & ($ Millions)
Figure 11. Global Adalimumab Drug Market Size Market Share by Application in 2021
Figure 12. Global Adalimumab Drug Revenue Market Share by Player in 2021
Figure 13. Global Adalimumab Drug Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Adalimumab Drug Market Size 2017-2022 ($ Millions)
Figure 15. APAC Adalimumab Drug Market Size 2017-2022 ($ Millions)
Figure 16. Europe Adalimumab Drug Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Adalimumab Drug Market Size 2017-2022 ($ Millions)
Figure 18. Americas Adalimumab Drug Value Market Share by Country in 2021
Figure 19. Americas Adalimumab Drug Consumption Market Share by Type in 2021
Figure 20. Americas Adalimumab Drug Market Size Market Share by Application in 2021
Figure 21. United States Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Adalimumab Drug Market Size Market Share by Region in 2021
Figure 26. APAC Adalimumab Drug Market Size Market Share by Application in 2021
Figure 27. China Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Adalimumab Drug Market Size Market Share by Country in 2021
Figure 34. Europe Adalimumab Drug Market Size Market Share by Type in 2021
Figure 35. Europe Adalimumab Drug Market Size Market Share by Application in 2021
Figure 36. Germany Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Adalimumab Drug Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Adalimumab Drug Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Adalimumab Drug Market Size Market Share by Application in 2021
Figure 44. Egypt Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Adalimumab Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 50. APAC Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 51. Europe Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 53. United States Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 54. Canada Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 57. China Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 58. Japan Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 59. Korea Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 61. India Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 62. Australia Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 63. Germany Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 64. France Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 65. UK Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 66. Italy Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 67. Russia Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 68. Spain Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 71. Israel Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Adalimumab Drug Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Adalimumab Drug Market Size 2023-2028 ($ Millions)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)